Patients and tumor characteristics | |
---|---|
Variable | Adenocarcinomas (n = 15) |
Sexa | |
 Female | 3 (20%) |
 Male | 12 (80%) |
Age at operationb | 73 (65–78) |
Clavien-Dindo ≥ IIIba | 5 (33%) |
Post-operative mortalitya | 3 (20%) |
DA on adenomaa | 3 (20%) |
Portion of duodenum involveda | |
 I | 1 (7%) |
 II | 13 (86%) |
 III | 1 (7%) |
 IV | 0 (0%) |
TNM staging 7th edition | |
 Ta | |
1–2 | 2 (13%) |
3–4 | 13 (87%) |
Na | |
 0 | 7 (47%) |
 1 | 2 (13%) |
 2 | 6 (40%) |
Stage grouping 7th editiona | |
 I | 2 (13%) |
 II | 5 (34%) |
 III | 8 (53%) |
Histological grade (G)a | |
 1–2 | 7 (46%) |
 3–4 | 8 (54%) |
Resection status (R)a | |
 0, n (%) | 14 (93%) |
 1, n (%) | 1 (7%) |
 2, n (%) | 0 (0%) |
n° of retrieved lymph nodesb | 23 (14–28) |
n° of positive lymph nodesb | 2 (0–3) |
Lymph node ratiob | 0.689 (0–0.115) |
Perineural invasiona | 5 (33%) |
Lymphovascular invasiona | 5 (33%) |
Adjuvant chemotherapya | 6 (40%) |
Adjuvant radiotherapya | 0 (0%) |
Disease recurrencea | 3 (20%) |
Disease related deatha | 3 (20%) |